Andreeff M - Search Results

1

Jab1/Csn5-Thioredoxin Signaling in Relapsed Acute Monocytic Leukemia under Oxidative Stress.

Zhou F, Pan Y, Wei Y, Zhang R, Bai G, Shen Q, Meng S, Le XF, Andreeff M, Claret FX. Zhou F, et al. Among authors: andreeff m. Clin Cancer Res. 2017 Aug 1;23(15):4450-4461. doi: 10.1158/1078-0432.CCR-16-2426. Epub 2017 Mar 7. Clin Cancer Res. 2017. PMID: 28270496 Free PMC article.

2

Clinical implications of decreased retinoblastoma protein expression in acute myelogenous leukemia.

Kornblau SM, Xu HJ, del Giglio A, Hu SX, Zhang W, Calvert L, Beran M, Estey E, Andreeff M, Trujillo J, et al. Kornblau SM, et al. Among authors: andreeff m. Cancer Res. 1992 Sep 1;52(17):4587-90. Cancer Res. 1992. PMID: 1511426

3

Induction of differentiation in myeloid leukemia cell lines and acute promyelocytic leukemia cells by liposomal all-trans-retinoic acid.

Drach J, Lopez-Berestein G, McQueen T, Andreeff M, Mehta K. Drach J, et al. Among authors: andreeff m. Cancer Res. 1993 May 1;53(9):2100-4. Cancer Res. 1993. PMID: 8481912

4

Low and maximally phosphorylated levels of the retinoblastoma protein confer poor prognosis in newly diagnosed acute myelogenous leukemia: a prospective study.

Kornblau SM, Andreeff M, Hu SX, Xu HJ, Patel S, Theriault A, Koller C, Kantarjian H, Estey E, Deisseroth AB, Benedict WF. Kornblau SM, et al. Among authors: andreeff m. Clin Cancer Res. 1998 Aug;4(8):1955-63. Clin Cancer Res. 1998. PMID: 9717825

5

Humanized M195 monoclonal antibody conjugated to recombinant gelonin: an anti-CD33 immunotoxin with antileukemic activity.

Pagliaro LC, Liu B, Munker R, Andreeff M, Freireich EJ, Scheinberg DA, Rosenblum MG. Pagliaro LC, et al. Among authors: andreeff m. Clin Cancer Res. 1998 Aug;4(8):1971-6. Clin Cancer Res. 1998. PMID: 9717827

6

PML/RARalpha, a fusion protein in acute promyelocytic leukemia, prevents growth factor withdrawal-induced apoptosis in TF-1 cells.

Fu S, Consoli U, Hanania EG, Zu Z, Claxton DF, Andreeff M, Deisseroth AB. Fu S, et al. Among authors: andreeff m. Clin Cancer Res. 1995 Jun;1(6):583-90. Clin Cancer Res. 1995. PMID: 9816019

7

Telomerase activity in human acute myelogenous leukemia: inhibition of telomerase activity by differentiation-inducing agents.

Zhang W, Piatyszek MA, Kobayashi T, Estey E, Andreeff M, Deisseroth AB, Wright WE, Shay JW. Zhang W, et al. Among authors: andreeff m. Clin Cancer Res. 1996 May;2(5):799-803. Clin Cancer Res. 1996. PMID: 9816233

8

Purging of contaminating breast cancer cells from hematopoietic stem cell grafts by adenoviral GAL-TEK gene therapy and magnetic antibody cell separation.

Marini FC, Snell V, Yu Q, Zhang X, Singletary SE, Champlin R, Andreeff M. Marini FC, et al. Among authors: andreeff m. Clin Cancer Res. 1999 Jun;5(6):1557-68. Clin Cancer Res. 1999. PMID: 10389945

9

The prognostic impact of BCL2 protein expression in acute myelogenous leukemia varies with cytogenetics.

Kornblau SM, Thall PF, Estrov Z, Walterscheid M, Patel S, Theriault A, Keating MJ, Kantarjian H, Estey E, Andreeff M. Kornblau SM, et al. Among authors: andreeff m. Clin Cancer Res. 1999 Jul;5(7):1758-66. Clin Cancer Res. 1999. PMID: 10430080

10

BAX and PKCalpha modulate the prognostic impact of BCL2 expression in acute myelogenous leukemia.

Kornblau SM, Vu HT, Ruvolo P, Estrov Z, O'Brien S, Cortes J, Kantarjian H, Andreeff M, May WS. Kornblau SM, et al. Among authors: andreeff m. Clin Cancer Res. 2000 Apr;6(4):1401-9. Clin Cancer Res. 2000. PMID: 10778970

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

795 results

Search Page

Filters